熱門資訊> 正文
Ensys Biosciences宣布500万美元同时发行，股价下跌
2024-08-30 03:36
- Ensysce Biosciences (NASDAQ:ENSC) said on Thursday it has entered into an agreement to issue 3.5M of its common shares at a price of $0.47 per share in a registered direct offering.
- The company also entered into agreements to exercise certain outstanding warrants to purchase 7.2M shares of common stock originally issued in February, with an exercise price of $1.06 per share, at a reduced exercise price of $0.47 per share.
- The gross proceeds from the concurrent offerings are expected to be approximately $5M.
- ENSC (ENSC) stock slipped about 35.2% during Thursday trading hours.
More on Ensysce Biosciences
- Ensysce wins $14M federal grant for lead pain therapy
- Seeking Alpha’s Quant Rating on Ensysce Biosciences
- Historical earnings data for Ensysce Biosciences
- Financial information for Ensysce Biosciences
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
